Loading...
XHKG
3332
Market cap16mUSD
Jul 08, Last price  
0.14HKD
1D
-2.84%
Jan 2017
-91.80%
IPO
-94.93%
Name

Nanjing Sinolife United Co Ltd

Chart & Performance

D1W1MN
XHKG:3332 chart
P/E
4.55
P/S
0.15
EPS
0.03
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
21.12%
Revenues
773m
+3.35%
150,372,000194,736,000252,449,000397,064,000466,241,000472,490,000453,199,000322,613,000296,525,000252,325,000274,851,000563,959,000747,898,000772,926,000
Net income
25m
-28.64%
57,237,00070,786,000107,873,000136,233,00087,232,0004,209,000-112,837,000-194,658,000-49,605,000-31,707,000-14,246,00052,602,00034,562,00024,665,000
CFO
69m
+7,071.26%
57,923,00082,076,00087,649,000104,658,00077,712,000-108,740,00030,577,000-68,136,00016,408,000421,0007,915,00047,109,000957,00068,629,000
Dividend
Jun 17, 20160.0757 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nanjing Sinolife United Company Limited functions as an investment holding entity primarily involved in the manufacturing, processing, and global distribution of nutritional supplements. Its operations span the People's Republic of China, Australia, New Zealand, Vietnam, and various international markets. The firm additionally produces and markets cosmetics and skincare items, while also undertaking the trading, retail, and testing of pre-packaged health food products. Products are sold under well-known brands such as Good Health, Zhongsheng, Hejian, and Cobayer, primarily via its comprehensive network of retail outlets. Distribution also encompasses sales through distributors, television shopping channels, online e-commerce platforms, chain pharmacies, specialized health food supermarkets, and tourist souvenir shops. The company, which has been headquartered in Nanjing, China, since its establishment in 1999.
IPO date
Jan 15, 2014
Employees
319
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT